Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Molecular Cancer Research : MCR|November 1, 2022
DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin SignalingYaqi Zhang, Yinu Wang, Andres Valdivia, et al.Journal of Medicinal Chemistry|July 14, 2023
Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2)Andres Valdivia, Purav P Vagadia, Guangxu Guo, et al.Frontiers in Oncology|February 12, 2024
E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cellsAndres Valdivia, Matthew Cowan, Horacio Cardenas, et al.European Journal of Medicinal Chemistry|October 8, 2025
Novel PROTACs targeting tissue transglutaminase (TG2) suppress tumorigenicity of ovarian cancer cellsAndres Valdivia, Joshua L Zhu, Vanessa Hernandez, et al.JCI Insight|February 18, 2025
Complement activation at the interface between adipocytes and cancer cells drives tumor progressionAndres Valdivia, Ana Maria Isac, Horacio Cardenas, et al.Molecular Metabolism|April 23, 2026
Oleic Acid Fuels Cisplatin-Resistant Ovarian Cancer Through FABP4-Driven Lipid UptakeAna Maria Isac, Andres Valdivia, Didi Zha, et al.Pageof 1